SEINE BIO · SCIENCE LIBRARY
5-Amino-1MQ
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide.
Research compoundA closer look at the research, the uncertainties and the questions worth asking.
THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026
Inside the science of 5-Amino-1MQ.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.
Overview
5-Amino-1MQ is a small-molecule NNMT inhibitor, despite being discussed alongside peptides. Researchers investigate whether altering this metabolic enzyme can affect body composition and related metabolic pathways. Its popularity does not change the central evidence gap: the cited work is preclinical, not proof of a safe human weight-management program.
Community Use
PeptideDosages publishes a 5-Amino-1MQ vial protocol. It is a community reference with an identifiable product format, not a validated medical dose or evidence that an injection is an appropriate route. Oral and injectable claims should be kept separate from the animal study they cite. Community protocol reference.
Doses, Durations & Cycles
Informal biohacking protocols and published regimens. Attributed website reports for education, not medical recommendations. Multiple publications document circulation; they do not establish a safe dose or validate a cycle.
| Route / formulation | Dose / reported phases | Frequency | Duration / break | Notes and source |
|---|---|---|---|---|
| Oral capsule | 50 mg/day for 1–2 weeks, then 100–150 mg/day. | Once daily. | 8–12 weeks. Break: 4–8 weeks. | Published informal biohacking claim The Peptide Catalog |
| Oral capsule or tablet | 50 mg/day for 1–2 weeks, then 100 mg/day; some reports use 150 mg/day divided into two administrations. | Once daily, or divided morning and midday. | 8–12 weeks. Break: 4–6 weeks. | Published informal biohacking claim Ground Truth Peptides |
| Subcutaneous | 2.5 mg for days 1–2, then 5 mg from day 3; separate split alternative 2.5 mg twice daily. | Once daily, or twice daily for the split alternative. | 8–12 weeks. Break: 4–6 weeks. | Published informal biohacking claim The Peptide Catalog |
| Subcutaneous | 2.5 mg for days 1–2, then 5 mg from day 3; optional 2.5 mg twice-daily split. | Once daily, or twice daily for the split alternative. | 8–12 weeks. Break: 4–6 weeks. | Published informal biohacking claim PeptideDosing.ca |
Important context: Oral and subcutaneous doses are not interchangeable. No human conversion, average dose or safe maximum is inferred.
Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.
No validated human dose or on/off wellness cycle is established by the primary evidence here. Animal exposure amounts and supplier capsule strengths do not define an effective adult dose. A numerical chart should label any amount as the exposure for the exact experimental species and route, with no animal-to-human conversion.
Research Findings
A 2024 study evaluated 5-Amino-1MQ in diet-induced obese mice, assessing metabolic effects, body composition, and pharmacokinetics. It investigated several research administration approaches and measured outcomes over a short experimental period. These are animal data; they cannot establish human tolerability or long-term benefit. Mouse metabolic study.
U.S. Approval & Access
No FDA-approved 5-Amino-1MQ weight-management medicine was identified. Describing an ingredient as a supplement, metabolic tool, or research chemical does not establish an authorized drug pathway. A clinician can discuss the evidence without promising that the requested molecule can lawfully be dispensed.
What It Does in the Body
NNMT participates in nicotinamide-related metabolism and methyl-group use. Inhibiting it is a research strategy for changing metabolic signaling, not the same as giving NAD+ or following a nutrition plan. A plausible enzyme target helps explain the hypothesis, but does not demonstrate that a person will lose fat or feel more energetic. Reliable onset, peak benefit, and duration for proposed human wellness use remain unknown.
Benefits & Reported Experiences
The mouse findings support scientific interest in metabolic effects. They do not show a reliable amount of fat loss, strength gain, or liver improvement in patients. Claims should be compared with human evidence, especially when a headline omits the species or treats biochemical changes as equivalent to clinical outcomes.
Side Effects & Risks
Human side-effect frequencies and long-term safety remain insufficiently characterized for a wellness regimen. Animal toxicology can flag questions, but cannot supply a complete patient risk profile. Lack of reported complaints on a community forum is also not evidence of safety, particularly when actual product identity and follow-up are uncertain.
Delivery Options
Research routes used in mice are not consumer administration recommendations. An oral listing, topical claim, and injectable vial may imply very different exposure. Without validated human pharmacology for that formulation, changing route or matching an advertised milligram number cannot resolve the uncertainty.
Product Quality & Storage
Ask whether the substance, salt, and formulation actually match the experiment being discussed. A laboratory purity claim addresses a limited quality question; it does not establish absorption, dosing precision in clinical care, or benefit. A small molecule should not be assumed to inherit the handling or evidence of an unrelated peptide. No validated patient-product storage directions are inferred from community vial charts or mouse-study materials.
Combinations & Interactions
There is no established human evidence here for stacking 5-Amino-1MQ with NAD+, exercise mimetics, stimulants, or GLP-1 drugs. Shared marketing themes are not combination evidence. If a community source proposes several ingredients, evaluate each separately and ask whether the actual combination has been studied in people.
Talking With Your Provider
For weight, fatigue, or metabolic concerns, begin with your symptoms and goals rather than a molecule list. A clinician can review established causes and options and explain where the NNMT research fits. Useful questions include what outcome would be measured and which available approach has evidence in a population resembling yours.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.
Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.
Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.
Questions worth bringing to your appointment.
- Are there alternatives that address my goal?
- If treatment is appropriate, what monitoring and follow-up would I need?
- Could my health history or current medicines change the risks?
Saved discussion topics 0
Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.
Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.
Explore your next step with SEINE BIO.
Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.
Explore consultations Back to Related wellness injectablesEducational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.
Bring your saved topics to your care team.
Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.
Choose saved topics for review →